Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buccal midazolam vs sublingual lorazepam for dyspnea relief in palliative cancer patients
TCTR20230502004Phase 4Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of midazolam, lorazepam in Dyspnoea (SOB), cancer, sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Mar 2019; status: completed.
02
Drugs
midazolamlorazepam
03
Conditions
Dyspnoea (SOB)cancer
Beyond the preview
Go deeper on TCTR20230502004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230502004.